These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 36481585)
21. Circulating microRNA profile unveils mechanisms of action of acitretin for psoriasis vulgaris. Chen L; Li J; Yao Y; Wang S; Zheng S; Ju X; Zhang B Bioengineered; 2021 Dec; 12(1):1838-1850. PubMed ID: 33975513 [TBL] [Abstract][Full Text] [Related]
22. Cyr61/CCN1 is involved in the pathogenesis of psoriasis vulgaris via promoting IL-8 production by keratinocytes in a JNK/NF-κB pathway. Wu P; Ma G; Zhu X; Gu T; Zhang J; Sun Y; Xu H; Huo R; Wang B; Shen B; Chen X; Li N Clin Immunol; 2017 Jan; 174():53-62. PubMed ID: 27856305 [TBL] [Abstract][Full Text] [Related]
23. Multifaceted targeting of cationic liposomes via co-delivery of anti-IL-17 siRNA and corticosteroid for topical treatment of psoriasis. Yadav K; Singh D; Singh MR; Pradhan M Med Hypotheses; 2020 Dec; 145():110322. PubMed ID: 33086162 [TBL] [Abstract][Full Text] [Related]
24. Selenium-Rich Yeast Peptide Fraction Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis in Mice by Inhibiting Inflammation via MAPK and NF-κB Signaling Pathways. Guo H; Li M; Liu H Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216231 [TBL] [Abstract][Full Text] [Related]
25. NF-κB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis. Yan S; Xu Z; Lou F; Zhang L; Ke F; Bai J; Liu Z; Liu J; Wang H; Zhu H; Sun Y; Cai W; Gao Y; Su B; Li Q; Yang X; Yu J; Lai Y; Yu XZ; Zheng Y; Shen N; Chin YE; Wang H Nat Commun; 2015 Jul; 6():7652. PubMed ID: 26138368 [TBL] [Abstract][Full Text] [Related]
26. Rutaecarpine inhibited imiquimod-induced psoriasis-like dermatitis via inhibiting the NF-κB and TLR7 pathways in mice. Li Y; Zhang G; Chen M; Tong M; Zhao M; Tang F; Xiao R; Wen H Biomed Pharmacother; 2019 Jan; 109():1876-1883. PubMed ID: 30551443 [TBL] [Abstract][Full Text] [Related]
27. Ginsenoside Rg1 abolish imiquimod-induced psoriasis-like dermatitis in BALB/c mice via downregulating NF-κB signaling pathway. Shi Q; He Q; Chen W; Long J; Zhang B J Food Biochem; 2019 Nov; 43(11):e13032. PubMed ID: 31502279 [TBL] [Abstract][Full Text] [Related]
28. Cinnamaldehyde inhibits psoriasis‑like inflammation by suppressing proliferation and inflammatory response of keratinocytes via inhibition of NF‑κB and JNK signaling pathways. Ding Z; Liu J; Qian H; Wu L; Lv M Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278486 [TBL] [Abstract][Full Text] [Related]
29. A Scoping Review on Use of Drugs Targeting the JAK/STAT Pathway in Psoriasis. Gómez-García F; Gómez-Arias PJ; Montilla-López A; Hernández-Parada J; Sanz-Cabanillas JL; Ruano J; Parra-Peralbo E Front Med (Lausanne); 2022; 9():754116. PubMed ID: 35280877 [TBL] [Abstract][Full Text] [Related]
30. Topical Delivery of ROS-Responsive Methotrexate Prodrug Nanoassemblies by a Dissolvable Microneedle Patch for Psoriasis Therapy. Zhou Y; Yang L; Lyu Y; Wu D; Zhu Y; Li J; Jiang D; Xin X; Yin L Int J Nanomedicine; 2023; 18():899-915. PubMed ID: 36824414 [TBL] [Abstract][Full Text] [Related]
31. Tofacitinib for the treatment of moderate-to-severe psoriasis. Chiricozzi A; Faleri S; Saraceno R; Bianchi L; Buonomo O; Chimenti S; Chimenti MS Expert Rev Clin Immunol; 2015 Apr; 11(4):443-55. PubMed ID: 25666451 [TBL] [Abstract][Full Text] [Related]
32. Ma Y; Kim BH; Yun SK; Roh YS Molecules; 2023 Feb; 28(4):. PubMed ID: 36838711 [TBL] [Abstract][Full Text] [Related]
33. Gene Profiling of a 3D Psoriatic Skin Model Enriched in T Cells: Downregulation of Rioux G; Turgeon F; Le-Bel G; Grenier C; Guérin SL; Pouliot R Cells; 2022 Sep; 11(18):. PubMed ID: 36139479 [TBL] [Abstract][Full Text] [Related]
34. Quercetin ameliorates imiquimod-induced psoriasis-like skin inflammation in mice via the NF-κB pathway. Chen H; Lu C; Liu H; Wang M; Zhao H; Yan Y; Han L Int Immunopharmacol; 2017 Jul; 48():110-117. PubMed ID: 28499194 [TBL] [Abstract][Full Text] [Related]
35. Cutaneous delivery of [1-(4-chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl]-methanol, an indole-3-carbinol derivative, mitigates psoriasiform lesion by blocking MAPK/NF-κB/AP-1 activation. Weng JR; Huang TH; Lin ZC; Alalaiwe A; Fang JY Biomed Pharmacother; 2019 Nov; 119():109398. PubMed ID: 31493747 [TBL] [Abstract][Full Text] [Related]
36. The Genetic Susceptibility to Psoriasis and the Relationship of Linked Genes to Our Treatment Options. Patel HA; Revankar RR; Pedroza ST; Graham S; Feldman SR Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569685 [TBL] [Abstract][Full Text] [Related]
37. NF-κB: an essential transcription factor in psoriasis. Goldminz AM; Au SC; Kim N; Gottlieb AB; Lizzul PF J Dermatol Sci; 2013 Feb; 69(2):89-94. PubMed ID: 23219896 [TBL] [Abstract][Full Text] [Related]
38. 'Psoriasis 1' reduces psoriasis‑like skin inflammation by inhibiting the VDR‑mediated nuclear NF‑κB and STAT signaling pathways. Sun W; Gao Y; Yu X; Yuan Y; Yi J; Zhang Z; Cheng Y; Li Y; Peng X; Cha X Mol Med Rep; 2018 Sep; 18(3):2733-2743. PubMed ID: 30015892 [TBL] [Abstract][Full Text] [Related]
39. Tryptanthrin ameliorates imiquimod-induced psoriasis in mice by suppressing inflammation and oxidative stress via NF-κB/MAPK/Nrf2 pathways. Xiong Y; Wang J; Wang S; Li H; Zhou X J Nat Med; 2023 Jan; 77(1):188-201. PubMed ID: 36378401 [TBL] [Abstract][Full Text] [Related]
40. CCN1 upregulates IL-36 via AKT/NF-κB and ERK/CEBP β-mediated signaling pathways in psoriasis-like models. Zhang J; Shu J; Sun H; Zhai T; Li H; Li H; Sun Y; Huo R; Shen B; Sheng H J Dermatol; 2023 Mar; 50(3):337-348. PubMed ID: 36376243 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]